SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062028
Filing Date
2023-11-09
Accepted
2023-11-09 16:08:29
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-20230930.htm   iXBRL 10-Q 2409480
2 EX-31.1 achv-ex31_1.htm EX-31.1 11569
3 EX-32.1 achv-ex32_1.htm EX-32.1 6690
4 GRAPHIC img226507810_0.jpg GRAPHIC 92506
5 GRAPHIC img226507810_1.jpg GRAPHIC 18468
  Complete submission text file 0000950170-23-062028.txt   8440221

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT achv-20230930_cal.xml EX-101.CAL 39414
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT achv-20230930_pre.xml EX-101.PRE 328871
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT achv-20230930_def.xml EX-101.DEF 248897
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT achv-20230930_lab.xml EX-101.LAB 444632
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT achv-20230930.xsd EX-101.SCH 58316
57 EXTRACTED XBRL INSTANCE DOCUMENT achv-20230930_htm.xml XML 1346765
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 231392413
SIC: 2835 In Vitro & In Vivo Diagnostic Substances